Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
08/15/2000 | US6103519 Recombinant dna including coding sequence and regulatory sequence for expression of l protein with modified or deleted regions; for hepatitis vaccines |
08/15/2000 | US6103515 Microorganism defective in preferential proteolytic acivities; for the therapy and prophylaxis of thrombosis, shock and coagulation defects; for use as diuretic, vasorelaxant and to control cardiovascular equlibrium |
08/15/2000 | US6103514 Protease |
08/15/2000 | US6103513 Novel proteolytic enzyme; for the treatment of immune, proliferative and degratory defects |
08/15/2000 | US6103512 Thermostable variants of neutral proteases of Bacillus stearothermophilus and Bacillus thermoproteolyticus |
08/15/2000 | US6103509 Modified glucose dehydrogenase |
08/15/2000 | US6103507 Protein used to raise an immunological response against a bacteria; bactericides |
08/15/2000 | US6103504 Streptomyces mutant lacking branched-chain amino acid transaminase activity, branched-chain oxo acid biosynthetic activity and lacking avermectin b-o-methyl transferase activity; for production of parasitides and anthelmintics |
08/15/2000 | US6103501 Recombinant protein which can be utilized as agonist or antagonist to its native cellular counterparts |
08/15/2000 | US6103500 Production of tissue factor pathway inhibitor |
08/15/2000 | US6103499 Inhibitors of human plasmin derived from the Kunitz domains |
08/15/2000 | US6103495 Direct expression of peptides into culture media |
08/15/2000 | US6103494 Nucleotide sequences which code protein associated with immmune response; for the detection of flea allergy dermatitis; for the detection of modulators of immune response |
08/15/2000 | US6103493 Genetically engineered polypeptide to be used as a diagnostic tool in the detection of compounds |
08/15/2000 | US6103491 Methods and compositions for identifying morphogen analogs |
08/15/2000 | US6103490 Heterologous polypeptides expressed in filamentous fungi, processes for making same, and vectors for making same |
08/15/2000 | US6103489 Cell-free protein synthesis system with protein translocation and processing |
08/15/2000 | US6103488 Nucleotide sequences coding a rhodobacter synthetase associated with efficient synthesis of ubiquinones |
08/15/2000 | US6103484 Method for immunodiagnosis of heartworm in mammals |
08/15/2000 | US6103477 Rho protein |
08/15/2000 | US6103476 Detectably labeled, dual conformation oligonucleotide probes, assays and kits |
08/15/2000 | US6103475 Excitatory amino acid receptor protein expression testing methods |
08/15/2000 | US6103470 Plasmid for delivery of nucleic acids to cells and methods of use |
08/15/2000 | US6103469 A polynucleotide which encodes a polypeptide; diagnosis and therapy; anticarcinogenic and antiinflammatory agents |
08/15/2000 | US6103466 Obtaining dna sample from mammal and determining if nucleotide sequence encodes a biologically active protein of myostatin; amplifying dna with primers flanking natural mutation which when present in both alleles results in muscular hyperplasia |
08/15/2000 | US6103463 Method of sorting a mixture of nucleic acid strands on a binary array |
08/15/2000 | US6103292 Food products containing structured triglycerides |
08/15/2000 | US6103244 Containing a heterologous insert encoding an immunogenic protein, wherein said insert was molecularly cloned directly into the viral genome into a unique restriction endonuclease cleavage site |
08/15/2000 | US6103238 Selectively deglycosylated human immunodeficiency virus type 1 envelope vaccines |
08/15/2000 | US6103237 More stable to purification than wild type mature hk2 polypeptide. |
08/15/2000 | US6103234 Antibody to an inflammatory cytokine, said inflammatory cytokine comprising a mature macrophage inflammatory protein -2 (mmip-2) |
08/15/2000 | US6103230 Methods for promoting wound healing and treating transplant-associated vasculopathy |
08/15/2000 | US6103229 Regulator gene from Ustilago maydis |
08/15/2000 | US6103226 Co-transfecting the cell with one or more expression vectors containing polynucleotides that encode tyrosine hydroxylase, aromatic l-amino acid decarboxylase and gtp cyclohydrolase. |
08/15/2000 | US6103224 N∇2 CSF-1 (short form) and carboxy truncated fragments thereof |
08/15/2000 | US6103112 MIPC chromatographic apparatus with improved temperature control |
08/15/2000 | US6102690 Bioethanol production from cellobiose; microorganism which expresses pyruvate decarboxylase, alcohol dehydrogenase, Klebsiella phospho-beta-glucosidase and Klebsiella (phosphoenolpyruvate-dependent phosphotransferase system) cellobiose-utilizing Enzyme II |
08/15/2000 | CA2296846A1 Dna fragments having basidiomycete-derived promoter activity and expression of foreign genes under control of the promoter activity |
08/15/2000 | CA2202280C Sugar modified nucleosides and their use for synthesis of oligonucleotides |
08/15/2000 | CA2196431C Icam-4 materials and methods |
08/15/2000 | CA2046601C Production and use of anthelmintic agents and protective immunogens |
08/15/2000 | CA1341086C Thermally stable and ph stable subtilisin analogs and method for production thereof |
08/15/2000 | CA1341085C Recombinant 2,5-diketogluconic acid reductase production |
08/15/2000 | CA1341083C Purified recombinant interleukin-2 and process for recovering and purifying same |
08/11/2000 | CA2260376A1 New metalloproteases of the neprilysin family |
08/10/2000 | WO2000046601A1 Detecting telomerase activity |
08/10/2000 | WO2000046595A1 Multichannel control in microfluidics |
08/10/2000 | WO2000046585A2 Method for enriching or depleting tumour cells obtained from a body fluid and kit suitable for this purpose |
08/10/2000 | WO2000046407A2 Methods of utilizing the tt virus |
08/10/2000 | WO2000046406A2 Arrays for investigating protein protein interactions |
08/10/2000 | WO2000046405A2 Methods for identifying drug targets based on genomic sequence data |
08/10/2000 | WO2000046402A1 Genomic analysis method |
08/10/2000 | WO2000046399A1 Method for predicting fiber length using qtl's and molecular markers |
08/10/2000 | WO2000046398A1 Use of fluorescent molecular beacons in the detection of methylated nucleic acids |
08/10/2000 | WO2000046394A2 Tryptophan synthase as a site of herbicide action |
08/10/2000 | WO2000046391A2 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof |
08/10/2000 | WO2000046386A2 Gene repair involving the induction of double-stranded dna cleavage at a chromosomal target site |
08/10/2000 | WO2000046385A1 Gene repair involving in vivo excision of targeting dna |
08/10/2000 | WO2000046383A2 Method of modulating metabolite biosynthesis in recombinant cells |
08/10/2000 | WO2000046382A1 Modification of lignin composition of gymnosperms |
08/10/2000 | WO2000046381A1 Recombinant expression of heterologous nucleic acids in protozoa |
08/10/2000 | WO2000046379A1 Campylobacter glycosyltransferases for biosynthesis of gangliosides and ganglioside mimics |
08/10/2000 | WO2000046378A2 Method of improving the primary energy metabolism of mammalian cell lines |
08/10/2000 | WO2000046377A1 Genetically engineered retroviral vector particles capable of infecting non-dividing cells |
08/10/2000 | WO2000046376A2 Particles for gene therapy |
08/10/2000 | WO2000046375A2 Methods for producing polypeptides in fungal cells |
08/10/2000 | WO2000046374A1 $i(candida albicans) srb-7 |
08/10/2000 | WO2000046373A1 Diagnostic and protective antigen gene sequences of ichthyophthirius |
08/10/2000 | WO2000046372A2 Pancreatic islet genes regulated by glucose |
08/10/2000 | WO2000046371A1 Tau-conotoxin peptides |
08/10/2000 | WO2000046370A1 P37ing1 compositions and methods of use |
08/10/2000 | WO2000046369A2 Polynucleotides related to pancreatic disease |
08/10/2000 | WO2000046368A1 Transporter gene octn3 |
08/10/2000 | WO2000046367A2 Proteins capable of triggering g2/m transition and of interacting with cdc2- and cyclin b |
08/10/2000 | WO2000046366A1 Isolation of nucleic acid molecules |
08/10/2000 | WO2000046365A1 Advanced antigen presentation platform |
08/10/2000 | WO2000046364A1 Fiber receptor-independent system for the propagation of adenoviral vectors |
08/10/2000 | WO2000046363A1 Method for determining base sequence for analysis to be used in the detection of nucleic acid |
08/10/2000 | WO2000046362A1 Transgenic plants |
08/10/2000 | WO2000046360A1 Improved helper dependent vector system for gene therapy |
08/10/2000 | WO2000046358A2 Arabidopsis thaliana derived frigida gene conferring late flowering |
08/10/2000 | WO2000046356A1 Polynucleotide encoding 2-hydroxyisoflavanone synthase |
08/10/2000 | WO2000046355A2 Telomerase reverse transcriptase transcriptional regulatory sequences |
08/10/2000 | WO2000046353A1 Sebocytes, sebocyte cell lines and applications thereof |
08/10/2000 | WO2000046350A1 Production of biomedical peptides and proteins in plants using transcomplementation systems |
08/10/2000 | WO2000046348A1 Method for inducing differentiation into adipocytes, compound regulating differentiation into adipocytes and method for screening the same |
08/10/2000 | WO2000046347A1 Genetic and epigenetic regulation of abc transporters and ect0-phosphatases for the modulation of drug resistance |
08/10/2000 | WO2000046346A1 1-deoxy-d-xylulose-5-phosphate reductoisomerases, and methods of use |
08/10/2000 | WO2000046344A2 Non-stochastic generation of genetic vaccines and enzymes |
08/10/2000 | WO2000046251A2 Human polyclonal antibodies from transgenic nonhuman animals |
08/10/2000 | WO2000046246A1 Alpha-2-macroglobulin therapies and drug screening methods for alzheimer's disease |
08/10/2000 | WO2000046245A2 Human antibiotic proteins |
08/10/2000 | WO2000046244A1 cDNA SEQUENCE OF AN INTERACTOR FANCIP1 OF THE FANCONI ANAEMIA PROTEIN OF COMPLEMENTATION GROUP A |
08/10/2000 | WO2000046240A2 Polypeptides involved in immune response |
08/10/2000 | WO2000046236A2 Novel rgs-containing molecules and uses thereof |
08/10/2000 | WO2000046233A1 Pigment protein from coral tissue |
08/10/2000 | WO2000045953A1 Device for selectively regulating the temperature of individual containers |
08/10/2000 | WO2000045852A1 Method of treating cancer by restoration of pp32 function |
08/10/2000 | WO2000045851A2 Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin |
08/10/2000 | WO2000045849A2 Use of cationic lipids to generate anti-tumor immunity |